Dutch agency invites requests for decentralised procedure slots
This article was originally published in SRA
Pharmaceutical companies wanting to obtain time slots during the second half of 2010 for submitting marketing authorisation applications under the European Union’s decentralised procedure with the Netherlands as the reference member state should contact the Dutch Medicines Evaluation Board1,2.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.